218 related articles for article (PubMed ID: 22622862)
1. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
[TBL] [Abstract][Full Text] [Related]
2. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532
[TBL] [Abstract][Full Text] [Related]
3. Serum 25-hydroxyvitamin D and breast cancer risk by pathological subtype (MCC-Spain).
Lope V; Castelló A; Mena-Bravo A; Amiano P; Aragonés N; Fernández-Villa T; Guevara M; Dierssen-Sotos T; Fernandez-Tardón G; Castaño-Vinyals G; Marcos-Gragera R; Moreno V; Salas-Trejo D; Diaz-Santos M; Oribe M; Romieu I; Kogevinas M; Priego-Capote F; Pérez-Gómez B; Pollán M
J Steroid Biochem Mol Biol; 2018 Sep; 182():4-13. PubMed ID: 29679754
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serum.
Mohr SB; Gorham ED; Alcaraz JE; Kane CI; Macera CA; Parsons JK; Wingard DL; Horst R; Garland CF
Cancer Causes Control; 2013 Mar; 24(3):495-504. PubMed ID: 23296455
[TBL] [Abstract][Full Text] [Related]
5. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.
Abbas S; Chang-Claude J; Linseisen J
Int J Cancer; 2009 Jan; 124(1):250-5. PubMed ID: 18839430
[TBL] [Abstract][Full Text] [Related]
6. Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India.
Sofi NY; Jain M; Kapil U; Seenu V; Kamal VK; Pandey RM
J Steroid Biochem Mol Biol; 2018 Jan; 175():55-59. PubMed ID: 27687737
[TBL] [Abstract][Full Text] [Related]
7. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case-Control Study.
Jamshidinaeini Y; Akbari ME; Abdollahi M; Ajami M; Davoodi SH
J Am Coll Nutr; 2016; 35(7):639-646. PubMed ID: 27331363
[TBL] [Abstract][Full Text] [Related]
9. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
Bilinski K; Boyages J
Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D status and breast cancer in Saudi Arabian women: case-control study.
Yousef FM; Jacobs ET; Kang PT; Hakim IA; Going S; Yousef JM; Al-Raddadi RM; Kumosani TA; Thomson CA
Am J Clin Nutr; 2013 Jul; 98(1):105-10. PubMed ID: 23697705
[TBL] [Abstract][Full Text] [Related]
11. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
[TBL] [Abstract][Full Text] [Related]
12. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
[TBL] [Abstract][Full Text] [Related]
14. Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan.
Kawase T; Matsuo K; Suzuki T; Hirose K; Hosono S; Watanabe M; Inagaki M; Iwata H; Tanaka H; Tajima K
Cancer Sci; 2010 May; 101(5):1234-40. PubMed ID: 20151981
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
16. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.
McCullough ML; Stevens VL; Patel R; Jacobs EJ; Bain EB; Horst RL; Gapstur SM; Thun MJ; Calle EE
Breast Cancer Res; 2009; 11(4):R64. PubMed ID: 19715600
[TBL] [Abstract][Full Text] [Related]
17. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.
Bertrand KA; Rosner B; Eliassen AH; Hankinson SE; Rexrode KM; Willett W; Tamimi RM
Breast Cancer Res Treat; 2015 Jan; 149(2):479-87. PubMed ID: 25543181
[TBL] [Abstract][Full Text] [Related]
18. Low pretreatment serum concentration of vitamin D at breast cancer diagnosis in postmenopausal women.
Machado MRM; de Sousa Almeida-Filho B; De Luca Vespoli H; Schmitt EB; Nahas-Neto J; Nahas EAP
Menopause; 2019 Mar; 26(3):293-299. PubMed ID: 30234730
[TBL] [Abstract][Full Text] [Related]
19. Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women.
Cheng TD; Song X; Beresford SAA; Ho GYF; Johnson KC; Datta M; Chlebowski RT; Wactawski-Wende J; Qi L; Neuhouser ML
Cancer Causes Control; 2017 Oct; 28(10):1053-1063. PubMed ID: 28900765
[TBL] [Abstract][Full Text] [Related]
20. Reproductive factors, nutritional status and serum 25(OH)D levels in women with breast cancer: A case control study.
Sofi NY; Jain M; Kapil U; Seenu V; R L; Yadav CP; Pandey RM; Sareen N
J Steroid Biochem Mol Biol; 2018 Jan; 175():200-204. PubMed ID: 29137944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
